BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen CT, Lu MY, Hsieh MH, Tsai PC, Hsieh TY, Yeh ML, Huang CI, Tsai YS, Ko YM, Lin CC, Chen KY, Wei YJ, Hsu PY, Hsu CT, Jang TY, Liu TW, Liang PC, Hsieh MY, Lin ZY, Huang CF, Huang JF, Dai CY, Chuang WL, Shih YL, Yu ML. Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison. World J Gastroenterol 2022; 28(2): 263-274 [PMID: 35110949 DOI: 10.3748/wjg.v28.i2.263]
URL: https://www.wjgnet.com/1007-9327/full/v28/i2/263.htm
Number Citing Articles
1
Chia-Yen Dai, Batbold Batsaikhan, Chung-Feng Huang. ‘One-stop-shop’ point-of-care hepatitis C RNA testing intervention in the prison – some issuesJournal of Hepatology 2024; 80(3): e106 doi: 10.1016/j.jhep.2023.07.037
2
Chung‐Feng Huang, Tyng‐Yuan Jang, Shun‐Chieh Yu, Shin‐Chung Huang, Shao‐Lun Ho, Ming‐Lun Yeh, Chih‐Wen Wang, Po‐Cheng Liang, Yu‐Ju Wei, Po‐Yao Hsu, Ching‐I Huang, Ming‐Yen Hsieh, Yi‐Hung Lin, Sung‐Lin Yu, Pey‐Fang Wu, Yu‐Han Chen, Shin‐Chi Chien, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Tso‐Jen Wang, Ming‐Lung Yu. Patient‐centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in TaiwanThe Kaohsiung Journal of Medical Sciences 2024; 40(1): 86 doi: 10.1002/kjm2.12780
3
Hsu-Heng Yen, Yang-Yuan Chen, Jun-Hung Lai, Hung-Ming Chen, Chih-Ta Yao, Siou-Ping Huang, I-Ling Liu, Ya-Huei Zeng, Fang-Chi Yang, Fu-Yuan Siao, Mei-Wen Chen, Pei-Yuan Su. Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness AnalysisJournal of Clinical Medicine 2022; 11(7): 1853 doi: 10.3390/jcm11071853
4
Ching-Chu Lo, Wei-Yi Lei, Ying-Che Huang, Jow-Jyh Hwang, Chen-Yu Lo, Chien-hung Lin, Hsu-sheng Cheng, Yee-Tam Liao, Po-Cheng Liang, Meng-Jau Chiou, Ming-Jong Bair, Chia-Yen Dai, Ming-Lung Yu. Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan – A multi-center collaborative care modelJournal of Microbiology, Immunology and Infection 2023; 56(4): 680 doi: 10.1016/j.jmii.2023.01.014
5
Chien-Hung Chen, Nien-Tzu Hsu, I-Chun Chen, Te-Sheng Chang, Shing Cheng, Shi-Yann Cheng, Hung-Ming Chen, Ming-Rong Harn, Chen-Kou Liu, Mao-Ting Yang, Shih-Lung Lu, Chun-Mei Tseng, Sheng-Nan Lu. Dual strategy involving hospital-based study and community-based screening to eliminate hepatitis C in remote areasJournal of the Formosan Medical Association 2024;  doi: 10.1016/j.jfma.2024.01.005
6
Yu-Chi Tsai, Ming-Lung Yu, Chou-Yuan Ko, Yi-Hsiang Hsin, Qi-Zhang Tsai, Chien-Wei Huang. Treatment effectiveness and side effects of patients with hepatitis C in the prisons of Southern Taiwan: a real-life retrospective analysisBMJ Open 2023; 13(6): e070490 doi: 10.1136/bmjopen-2022-070490
7
Chi‐Ming Tai, Ming‐Lung Yu. Hepatitis C virus micro‐elimination in people who inject drugs: Challenges and chance in Taiwan and worldwideThe Kaohsiung Journal of Medical Sciences 2024; 40(2): 112 doi: 10.1002/kjm2.12788
8
Hsuan-Yuan Chang, Su-Hung Wang, Hsing-Tao Kuo, Ming-Jen Sheu, I-Che Feng, Chung-Han Ho, Jui-Yi Chen, Chi-Shu Sun, Chi-Hsing Chen, Cheng-Yi Lin, Chun-Chi Yang, Dirk Uhlmann. The Efficacy of On-Site Integration Screening and Microelimination Programs for Chronic Hepatitis C in a Detection Center: A Comparison of the Treatment Outcomes and Characteristics of Incarcerated Patients and OutpatientsInternational Journal of Hepatology 2024; 2024: 1 doi: 10.1155/2024/3184892
9
Chung-Feng Huang, Guan-Jhou Chen, Chien-Ching Hung, Ming-Lung Yu. HCV Microelimination for High-risk Special PopulationsThe Journal of Infectious Diseases 2023; 228(Supplement_3): S168 doi: 10.1093/infdis/jiac446